Lowinson, J.H., Payte, J.T., Joseph, H., Marion, I.J., and Dole, V.P. (1992). Methadone maintenance. In J.H. Lowinson, P. Ruiz, R.B. Millman, and J.G. Langrod (Eds.), Substance abuse: A comprehensive textbook (pp. 405-414). Philadelphia: Williams and Wilkins.
Martin, S.S., Butzin, C.A., Saum, C.A., and Inciardi, J.A. (1999). Three-year outcomes of therapeutic community treatment for drug-involved offenders in Delaware: From prison to work release to aftercare. Prison Journal, 79(3), 294-320.
McFarland, B.H., Lierman, W.K., Penner, N.R., McCamant, L.E., and Zani, B.G. (2003). Employee benefits managers’ opinions about addiction treatment. Journal of Addictive Diseases, 22(2), 15-29.
McLellan, A.T., Arndt, I.O., Metzger, D.S., Woody, G.E., and O’Brien, C.P. (1993). The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association, 269(15), 1953-1959.
McLellan, A.T., O’Brien, C.P., Lewis, D., and Kleber, H.D. (2000). Drug addiction as a chronic medical illness: Implications for treatment, insurance and evaluation. Journal of the American Medical Association, 284(13), 1689-1695.
Metzger, D.S., Navaline, H., and Woody, G.E. (1998). Drug abuse treatment as AIDS prevention. Public Health Reports, 113(Suppl 1), 97-106.
Morris, P.L., Hopwood, M., Whelan G., Gardiner, J., and Drummond, E. (2001). Naltrexone for alcohol dependence: A randomized controlled trial. Addiction, 96(11), 1565-1573.
National Institutes of Health Consensus Conference. (1998). Effective medical treatment of opiate addiction. Journal of the American Medical Association, 280(22), 1936-1943.
Office of National Drug Control Strategy. (2002). 2002 Final report on the 1998 National Drug Control Strategy: Performance measures of effectiveness. Available:http://www.whitehousedrugpolicy.gov/publications/policy/02pme/pmepdf/pme.pdf [January 2, 2004].
Oslin, D.W., Berrettini, W., Kranzler, H.R., Penninati, H., Gelernter, J., Volpicelli, J.R., and O’Brien, C.P. (2003). A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients. Neuropsychopharmacology, 28(8), 1546-1552.
Peters, R.H., May, R.I., and Kearns, W.D. (1992). Drug treatment in jails: Results of a nationwide survey. Journal of Criminal Justice, 20, 283-295.
Resnick, R.B., Washton, A.M., and Stone-Washton, N. (1981). Psychotherapy and naltrexone in opioid dependence. In L.S. Harris (Ed.), Problems of drug dependence (pp. 109-115). Rockville, MD: U.S. Department of Health and Human Services.
Shichor, D., and Sechrest, D. (2001). Introduction: Special issue on drug courts. Journal of Drug Issues, 31, 1-6.
Shoptaw, S., Frosch, D.L., Rawson, R.A., and Ling, W. (1997). Cocaine abuse counseling as HIV prevention. AIDS Education and Prevention, 9(6), 511-520.
Woody, G.E. (2003). Treating dually diagnosed patients. Psychiatric Times, 20(1), 29-30.
Woody, G.E., Gallop, R., Luborsky, L., Blaine, J., Frank, A., Gastfriend, D., Crits-Christoph, P., and the Cocaine Psychotherapy Study Group. (2003). HIV risk reduction in the NIDA cocaine psychotherapy study. Journal of Acquired Immune Deficiency Syndromes, 33(1), 82-87.